Intelligent Bio Solutions Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-12.4M | $-10.6M | $-10.2M | $-10.6M | $-8.3M | $-7.0M | $-3.2M |
| Depreciation & Amortization | $1.2M | $970.1K | $974.4K | $814.5K | — | — | — |
| Depreciation | $68.3K | $27.1K | $15.1K | $33.8K | $0 | — | — |
| Amortization | $1.2M | $949.3K | $947.4K | $805.8K | $0 | — | — |
| Stock-Based Compensation | $195.2K | $238.0K | $230.5K | $260.0K | — | — | — |
| Net Cash from Operating Activities | $-11.9M | $-9.7M | $-9.6M | $-7.4M | $-3.4M | $-11.3M | $-498.6K |
| Investing Activities | |||||||
| Capital Expenditures | $125.7K | $231.8K | $221.4K | — | — | — | — |
| Business Acquisitions | — | — | — | $363.5K | — | — | — |
| Net Cash from Investing Activities | $-85.6K | $-231.8K | $-221.4K | $-694.1K | $-880.2K | — | $-14.0K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $15.0M | $4.6M | $14.6M | $1.4M | — | $23.4M | $733.9K |
| Net Change in Cash | $3.0M | $-5.3M | $4.8M | $-6.7M | $-4.3M | $12.1M | $229.3K |
| Free Cash Flow | $-12.1M | $-9.9M | $-9.8M | — | — | — | — |